Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cypherpunk Technologies Total Payout Ratio Related Terms
Cypherpunk Technologies Total Payout Ratio Historical Data
* Premium members only.
The historical data trend for Cypherpunk Technologies's Total Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:5MC vs WIA, OPP, NRO: Total Payout Ratio Comparison
For the Asset Management subindustry, Cypherpunk Technologies's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cypherpunk Technologies Total Payout Ratio vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Cypherpunk Technologies's Total Payout Ratio distribution charts can be found below:
* The bar in red indicates where Cypherpunk Technologies's Total Payout Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cypherpunk Technologies (STU:5MC) has a Total Payout Ratio of 16.00 as of Aug. 31, 2026. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Cypherpunk Technologies and its competitors.
Is Cypherpunk Technologies' Total Payout Ratio too high?
Cypherpunk Technologies' current Total Payout Ratio is 16.00. Overall, Cypherpunk Technologies has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cypherpunk Technologies' Total Payout Ratio compare to WIA and OPP?
Cypherpunk Technologies' Total Payout Ratio of 16.00 can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Ratio for an Asset Management company?
A good Total Payout Ratio depends on the Asset Management industry context. However, Total Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Ratio mean?
A high Total Payout Ratio can signal that a stock is expensive relative to its fundamentals. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Cypherpunk Technologies and its competitors. Cypherpunk Technologies's current Total Payout Ratio is 16.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cypherpunk Technologies stock overvalued right now?
Based on GuruFocus' analysis, Cypherpunk Technologies (STU:5MC) is currently considered Possible Value Trap. The stock's GF Value™ is €17.67, compared to a current price of €1.47 — trading 91.7% below its estimated fair value. The current Total Payout Ratio is 16.00. Cypherpunk Technologies' overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Ratio calculated?
Total Payout Ratio is calculated from a company's financial statements. For Cypherpunk Technologies (STU:5MC), the current Total Payout Ratio is 16.00 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cypherpunk Technologies (STU:5MC) Overvalued in 2026?
Based on GuruFocus' analysis, Cypherpunk Technologies stock appears to be undervalued.
The current stock price of €1.47 is trading 91.7% below its estimated GF Value™ of €17.67.
GuruFocus considers Cypherpunk Technologies to be Possible Value Trap.
Key valuation signals for STU:5MC:
Total Payout Ratio: 16.00
GF Value™: €17.67 vs. price of €1.47 (91.7% below fair value)
No single metric tells the full story. See the STU:5MC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
52GF Score
Get the complete analysis for STU:5MC
Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:5MC has been successfully added to your 
